Extended SIR Prediction of the Epidemics Trend of COVID-19 in Italy and Compared With Hunan, China

Background: Coronavirus Disease 2019 (COVID-19) is currently a global public health threat. Outside of China, Italy is one of the countries suffering the most with the COVID-19 epidemic. It is important to predict the epidemic trend of the COVID-19 epidemic in Italy to help develop public health strategies. Methods: We used time-series data of COVID-19 from Jan 22 2020 to Apr 02 2020. An infectious disease dynamic extended susceptible-infected-removed (eSIR) model, which covers the effects of different intervention measures in dissimilar periods, was applied to estimate the epidemic trend in Italy. The basic reproductive number was estimated using Markov Chain Monte Carlo methods and presented using the resulting posterior mean and 95% credible interval (CI). Hunan, with a similar total population number to Italy, was used as a comparative item. Results: In the eSIR model, we estimated that the mean of basic reproductive number for COVID-19 was 4.34 (95% CI, 3.04–6.00) in Italy and 3.16 (95% CI, 1.73–5.25) in Hunan. There would be a total of 182 051 infected cases (95%CI:116 114–274 378) under the current country blockade and the endpoint would be Aug 05 in Italy. Conclusion: Italy's current strict measures can efficaciously prevent the further spread of COVID-19 and should be maintained. Necessary strict public health measures should be implemented as soon as possible in other European countries with a high number of COVID-19 cases. The most effective strategy needs to be confirmed in further studies.

[1]  C. Eastin,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The Journal of Emergency Medicine.

[2]  Nuno R. Faria,et al.  The effect of human mobility and control measures on the COVID-19 epidemic in China , 2020, Science.

[3]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[4]  N. Linton,et al.  Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) , 2020, International Journal of Infectious Diseases.

[5]  Elisabeth Mahase,et al.  China coronavirus: what do we know so far? , 2020, BMJ.

[6]  Nuno R. Faria,et al.  The effect of human mobility and control measures on the COVID-19 epidemic in China , 2020, medRxiv.

[7]  C. Viboud,et al.  Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study , 2020, The Lancet Digital Health.

[8]  Quanyi Wang,et al.  Early evaluation of transmission control measures in response to the 2019 novel coronavirus outbreak in China , 2020 .

[9]  Marta Giovanetti,et al.  The first two cases of 2019‐nCoV in Italy: Where they come from? , 2020, Journal of medical virology.

[10]  M. Baguelin,et al.  Report 3: Transmissibility of 2019-nCoV , 2020 .

[11]  Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) , 2020, medRxiv.

[12]  W. Liang,et al.  Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions , 2020, Journal of thoracic disease.

[13]  Ruifu Yang,et al.  The impact of transmission control measures during the first 50 days of the COVID-19 epidemic in China , 2020, medRxiv.

[14]  Jessica T Davis,et al.  The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak , 2020, Science.

[15]  L. Yang,et al.  Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak , 2020, bioRxiv.

[16]  C. Distante,et al.  Covid-19 Outbreak Progression in Italian Regions: Approaching the Peak by March 29th , 2020, medRxiv.

[17]  Xinxin Zhang,et al.  Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China , 2020, Cell Discovery.

[18]  Yaqing Fang,et al.  Transmission dynamics of the COVID‐19 outbreak and effectiveness of government interventions: A data‐driven analysis , 2020, Journal of medical virology.

[19]  Mattia Prosperi,et al.  The global spread of 2019-nCoV: a molecular evolutionary analysis , 2020, Pathogens and global health.

[20]  Y. Moreno,et al.  Evaluation of the potential incidence of COVID-19 and effectiveness of containment measures in Spain: a data-driven approach , 2020, BMC Medicine.

[21]  Jianhong Wu,et al.  Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions , 2020, Journal of clinical medicine.

[22]  T. Mkhatshwa,et al.  Modeling Super-spreading Events for Infectious Diseases: Case Study SARS , 2010, 1007.0908.

[23]  L. Yang,et al.  Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak , 2020, International Journal of Infectious Diseases.

[24]  Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China. , 2020, Cell discovery.

[25]  Data Driven Analysis , 2020, Definitions.

[26]  Lu Tang,et al.  An epidemiological forecast model and software assessing interventions on COVID-19 epidemic in China , 2020, medRxiv.

[27]  D. Cummings,et al.  Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions , 2020, medRxiv.

[28]  T. Hollingsworth,et al.  How will country-based mitigation measures influence the course of the COVID-19 epidemic? , 2020, The Lancet.

[29]  Cosimo Distante,et al.  Covid-19 Outbreak Progression in Italian Regions: Approaching the Peak by the End of March in Northern Italy and First Week of April in Southern Italy , 2020, International journal of environmental research and public health.

[30]  E. Dong,et al.  An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.

[31]  Guo-Jing Yang,et al.  Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province , 2020, medRxiv.

[32]  Salvatore Rubino,et al.  Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. , 2020, Journal of infection in developing countries.

[33]  J. Hyman,et al.  Real-time forecasts of the 2019-nCoV epidemic in China from February 5th to February 24th, 2020 , 2020, 2002.05069.

[34]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[35]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[36]  K. Hattaf,et al.  A delayed SIR epidemic model with a general incidence rate , 2013 .

[37]  J. Rocklöv,et al.  The reproductive number of COVID-19 is higher compared to SARS coronavirus , 2020, Journal of travel medicine.

[38]  Qun Li Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020 .

[39]  G. Leung,et al.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study , 2020, The Lancet.

[40]  Ruifu Yang,et al.  An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China , 2020, Science.

[41]  X. Liao,et al.  Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, China , 2020, Intensive Care Medicine.